Chronic Respiratory Diseases and Mucolytic Efficacy: Examining the Clinical Evidence Sustaining the Traditional Use of N-Acetylcysteine.
The traditional therapeutic mainstay of N-Acetylcysteine (NAC) continues to be in the management of chronic and acute **pulmonary diseases**. Its potent **mucolytic** action makes it an indispensable tool for patients suffering from conditions characterized by excessive and thick airway mucus, most notably Chronic Obstructive Pulmonary Disease (COPD) and cystic fibrosis. In COPD, the chronic...
0 Комментарии 0 Поделились 190 Просмотры 0 предпросмотр
MTSocial https://mtsocial.ir